Dr. Kamal Menghrajani received her MD from the University of North Carolina at Chapel Hill. She completed her Internal Medicine residency at the University of Michigan, and her fellowship and chief fellowship in hematology and medical oncology at Memorial Sloan Kettering Cancer Center. Kamal subsequently joined the faculty at MSK on the leukemia service, where she used computational biology, genomics, and population sciences to study clonal hematopoiesis and myeloid diseases. She was the recipient of an NIH K award, an ASCO YIA, and she earned a Masters degree in Biostatistics from the Mailman School of Public Health at Columbia University. In 2023, Dr. Menghrajani was asked to join the White House to serve as the oncologist for the Cancer Moonshot and the physician for the Health Outcomes team. As a White House Fellow and then an Assistant Director at the White House Office of Science and Technology Policy, Dr. Menghrajani created and executed strategic initiatives around cell & gene therapy, global health, clinical trials, rare diseases, the decline in life expectancy, and more.